Encysive Pharmaceuticals logo

Encysive Pharmaceuticals

Leading the fight against vascular and inflammatory diseases with groundbreaking synthetic and small molecule compounds.

est. 1989

VS
Salubris Biotherapeutics logo

Salubris Biotherapeutics

41 employees · est. 2016 · Gaithersburg, United States

Encysive Pharmaceuticals is the older company (1989 vs 2016).

Side-by-Side Comparison

Encysive Pharmaceuticals Salubris Biotherapeutics
Founded
1989 older 2016
Headquarters
Not tracked yet Gaithersburg, United States
Employees
Not tracked yet 41
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Pharmaceutical
Funding Stage
Private Equity Series A
Total Funding
$88.95M Not tracked yet
Funding Rounds
2 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical Company, Medical Research, Vascular Diseases, Inflammatory Diseases, Small Molecule Compounds, Endothelin Receptor Antagonist, Clinical Development, Therapeutic Compounds, Collaboration Agreements, Pulmonary Arterial Hypertension, Global Medical Needs, Drug Discovery, Medical Innovation Not tracked yet
Website
encysive.com salubrisbio.com
Encysive Pharmaceuticals logo

About Encysive Pharmaceuticals

Encysive Pharmaceuticals, Inc. is a pioneering biopharmaceutical company focused on combatting vascular and inflammatory diseases through the development and commercialization of synthetic and small molecule compounds. The company's dedication to research and development is evident in its range of p...

Salubris Biotherapeutics logo

About Salubris Biotherapeutics

SalubrisBio was founded in August 2016 as a subsidiary of the China-based pharmaceutical company Salubris Pharmaceuticals Co. Ltd. (www.salubris.com). SalubrisBio is an innovation-focused biotech with pioneering research and development programs. Headquartered in Gaithersburg, Maryland, SalubrisBio...

We will tell you when either one moves

BounceWatch watches Encysive Pharmaceuticals and Salubris Biotherapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Encysive Pharmaceutica... and Salubris Biotherapeuti... — by email.

Frequently Asked Questions

Encysive Pharmaceuticals — Leading the fight against vascular and inflammatory diseases with groundbreaking synthetic and small molecule compounds.. Salubris Biotherapeutics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Encysive Pharmaceuticals has raised $88.95M while Salubris Biotherapeutics has raised undisclosed funding.
Encysive Pharmaceuticals and Salubris Biotherapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Encysive Pharmaceuticals with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Encysive Pharmaceuticals on 12 Sep 2024, and Salubris Biotherapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes